An integrated approach to Chlamydia trachomatis infection: The ICTI consortium, an update

Drugs of Today

Volumn 45, Issue SUPPL. B, 2009, Pages 15-23

  Lyons, J M ^a   Ouburg, S ^b   Morre S A ^b  

^a Integrated Disease Modeling   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GAMMA INTERFERON; TOLL LIKE RECEPTOR 4;

BACTERIAL TRANSMISSION; CHLAMYDIAL URETHRITIS; CHLAMYDIASIS; CONFERENCE PAPER; DISEASE COURSE; FEMALE INFERTILITY; GENETIC EPIDEMIOLOGY; GENOMICS; HUMAN; IMMUNOPATHOGENESIS; INFECTION SENSITIVITY; NONHUMAN; PELVIC INFLAMMATORY DISEASE; SEXUALLY TRANSMITTED DISEASE;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COOPERATIVE BEHAVIOR; DISEASE MODELS, ANIMAL; FEMALE; GENITAL DISEASES, FEMALE; HUMANS;

EID: 71249133455     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. Morré, S.A., Spaargaren, J., Ossewaarde, J.M. et al. Description of the ICTI consortium: An integrated approach to the study of chlamydia trachomatis infection. Drugs Today (Barc) 2006, 42(Suppl. A): 107-114
2. Scholes, D., Stergachis, A., Heidrich, F.E., Andrilla, H., Holmes, K.K., Stamm, W.E. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996, 334: 1362-1366 (Pubitemid 26152715)
3. van Valkengoed, I.G., Morré, S.A., van den Brule, A.J. et al. Follow-up, treatment, and reinfection rates among asymptomatic Chlamydia trachomatis cases in general practice. Br J Gen Pract 2002, 52(481): 623-627
4. Gerbase, A.C., Rowley, J.T., Heymann, D.H., Berkley, S.F., Piot, P. Global prevalence and incidence estimates of selected curable STDs. Sex Trans Infect 1998, 74(Suppl. 1): S12-6. (Pubitemid 28331201)
5. Miller, W.C., Ford, C.A, Morris, M. et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004, 291: 2229-2236 (Pubitemid 38608172)
6. van Valkengoed, I.G.M., Morré, S.A., van den Brule, A.J.C., Meijer, C.J.L.M., Bouter, L.M., Boeke, A.J.P. Overestimation of complication-rates of Chlamydia trachomatis screening programmes: Implications for cost-effectiveness analyses. Int J Epidemiol 2004, 33: 416-425
7. Hillis, S.D., Owens, L.M., Marchbanks, P.A., Amsterdam, L.F., MacKenzie, W.R. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997, 176: 103-107
8. van Valkengoed, I.G., Morré, S.A., van den Brule, A.J., Meijer, C.J., Bouter, L.M., van Eijk, J.T., Boeke, A.J. Partner notification among asymptomatic Chlamydia trachomatis cases, by means of mailed specimens. Br J Gen Pract 2002, 52(481): 652-654
9. Lin, J-S.L., Donegan, S.P., Heeren, T.C. et al. Transmission of Chlamydia trachomatis and Neisseria gonorrhoeae among men with urethritis and their female sex partners. J Infect Dis 1998, 178: 1707-1712
10. van Valkengoed, I.G., Morré, S.A., van den Brule, A.J., Meijer, C.J., Bouter, L.M., van Eijk, J.T., Boeke, A.J. Follow-up, treatment, and reinfection rates among asymptomatic chlamydia trachomatis cases in general practice. Br J Gen Pract 2002, 52(481): 623-627
11. Zimmermann, H.L., Potterat, J.J., Dukes, R.L., Muth, J.B., Zimmermann, H.O., Fogle, J.S., Pratts, C.I. Epidemiologic differences between chlamydia and gonorrhea. Am J Public Health 1990, 80: 1338-1342
12. Stamm, W.E. Diagnosis of Chlamydia trachomatis genitourinary infections. Ann Intern Med 1988, 108: 710-717 (Pubitemid 18110947)
13. Morré, S.A., Rozendaal, L., van Valkengoed, I.G.M. et al. Urogenital Chlamydia trachomatis serovars in men and women having either a symptomatic or an asymptomatic infection: An association with clinical manifestations? J Clin Microbiol 2000, 38(6): 2292-2296
14. Morré, S.A. Chlamydia trachomatis Infections in the Human Urogenital Tract. Detection, Typing and Clinical Aspects. Thesis, VUmc, Amsterdam: 1999.
15. Golden, M.R., Schillinger, J.A., Markowitz, L., St. Louis, M.E. Duration of untreated genital infections with Chlamydia trachomatis. A review of the literature. Sex Transm Dis 2000, 27: 329-337
16. Morré, S.A., van den Brute, A.J., Rozendaal, L., Boeke, A.J., Voorhorst, F.J., de Blok, S., Meijer, C.J. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearonce and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002, 13(Suppl. 2): 12-18 (Pubitemid 35417213)
17. Golden, M.R., Whittington, W.L., Handsfield, H.H. et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005, 352(7): 676-685
18. Weström, L., Joesoef, R., Reynolds, G., Hadgu, A., Tompson, S.E. Pelvic inflammatory disease and fertility. A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Trans Dis 1992, 19: 185-192
19. Morré, S.A., Ouburg, S., Brand, A. The EU FP6 EpiGenChamydia Consortium: Contribution of molecular epidemiology and host-pathogen genomics to understanding Chlamydia trachomatis-related disease. Drugs Today (Barc) 2009, 45(Suppl. B): 7-13.
20. Morré, S.A., Karimi, O., Ouburg, S. Chlamydia trachomatis: Identification of susceptibility markers for ocular and sexually transmitted infection by immunogenetics. FEMS Immunol Med Microbiol 2009, 55(2): 140-153
21. Catsburg, A., van Dommelen, L., Smelov, V. et al. TaqMan Assay for Swedish Chlamydia trachomatis variant. Emerg Infect Dis 2007, 13(9): 1432-1434 (Pubitemid 47510325)
22. Lyons, J.M., Ito, J.I., Jr, Pena, A.S., Morré, S.A. Differences in growth characteristics and elementary body associated cytotoxicity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum. J Clin Pathol 2005, 58(4): 397-401.
23. Lyons, J., Igletseme, J.U., Black, C.M., Morré, S.A. Identification of candidate genes using the murine model of female genital tract infection with Chlamydia trachomatis. Drugs Today (Barc) 2009, 45(Suppl. B): 51-59.
24. Ito, J.I., Jr, Lyons, J.M., Airo-Brown, L.P. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect Immun 1990, 58(6): 2021-2023
25. Bax, C.J., Dorr, P.J., Trimbos, J.B., Spaargaren, J., Oostvogel, P.M., Pena, A.S., Morré, S.A. Chlamydia trachomatis heat shock protein 60 (cHSP60) antibodies in women without and with tubal pathology using a new commercially available assay. Sex Transm Infect 2004, 80(5): 415-416 (Pubitemid 39389565)
26. Bax, C.J., Mutsaers, J.A., Jansen, C.L., Trimbos, J.B., Dorr, P.J., Oostvogel, P.M. Comparison of serological assays for detection of Chlamydia trachomatis antibodies in different groups of obstetrical and gynecological patients. Clin Diagn Lab Immunol 2003, 10(1): 174-176
27. Bax, C.J., Oostvogel, P.M., Mutsaers, J.A., Brand, R., Craandijk, M., Trimbos, J.B., Dorr, P.J. Clinical characteristics of Chlamydia trachomatis infections in a general outpatient department of obstetrics and gynaecology in the Netherlands. Sex Transm Infect 2002, 78(6): E6.
28. Vanrompay, D., Hoang, T.Q.T, De Vos, L., Verminnen, K., Chiers, K., Morré, S.A., Cox, E. Specific pathogen free pigs as an additional animal model for studying Chlamydia trachomatis genital infection. Infect Immun 2005, 73(12): 8317-8321 (Pubitemid 41740322)
29. Vanrompay, D., Cox, E., Volckaert, G., Goddeeris, B. Turkeys are protected from infection with Chlamydia psittaci by plasmid DNA vaccination against the major outer membrane protein. Clin Exp Immunol 1999, 118(1): 49-55. (Pubitemid 29479783)
30. Vanrompay. D., Charlier, G., Ducatelle, R., Haesebrouck, F. Ultrastructural changes in avian Chlamydia psittaci serovar A-, S-, and D-infected Buffalo Green Monkey cells. Infect Immun 1996, 64(4): 1265-1271
31. Morré, S.A., Ossewaarde, J.M., Savelkoul, P.H., Stoof, J., Meijer, C.J., van den Brule, A.J. Analysis of genetic heterogeneity in Chlamydia trachomatis clinical isolates of serovars D, E, and F by amplified fragment length polymorphism. J Clin Microbiol 2000, 38(9): 3463-3466 (Pubitemid 30693952)
32. Meijer, A., Morré, S.A., van den Brule, A.J., Savelkoul, P.H., Ossewaarde, J.M. Genomic relatedness of Chlamydia isolates determined by amplified fragment length polymorphism analysis. J Bacteriol 1999, 181(15): 4469-4475 (Pubitemid 29357924)
33. Peters, R.P., van Agtmael, M.A., Danner, S.A., Savelkoul, P.H., Vandenbroucke-Grauls, C.M. New developments in the diagnosis of bloodstream infections. Lancet Infect Dis 2004, 4(12): 751-760 (Pubitemid 39574347)
34. Nieuwenhuis, R.F., Ossewaarde, J.M., Götz, H.M. et al. Resurgence of lymphogranuloma venereum in Western Europe: An outbreak of Chlamydia trachomatis serovar 12 proctitis in the Netherlands among men who have sex with men. Clin Infect Dis 2004, 39(7): 996-1003.
35. Ossewaarde, J.M., Meijer, A. Molecular evidence for the existence of additional members of the order Chlamydiales. Microbiology 1999, 145 (Pt 2): 411-417 (Pubitemid 29090096)
36. van der Snoek, E.M., Ossewaarde, J.M., van der Meijden, W.I., Mulder, R.G., Thio, H.B. The use of serological titres of IgA and IgG in (early) discrimination between rectal infection with non-lymphogranuloma venereum and lymphogranuloma venereum serovars of Chlamydia trachomatis. Sex Transm Infect 2007, 83(4): 330-334
37. Pannekoek, Y., Heurgue-Hamard, V., Langerak, A.A., Speijer, D., Buckingham, R.H., van der Ende, A. The N5-glutamine S-adenosyl-L-methionine- dependent methyltransferase PrmC/HemK. In Chlamydia trachomatis methylates class 1 release factors. J Bacteriol 2005, 187(2): 507-511
38. Pannekoek, Y., Morelli, G., Kusecek, B., Morre, S.A., Ossewaarde, J.M., Langerak, A.A., van der Ende, A. Multi locus sequence typing of Chlamydiales: Clonal groupings within the obligate intracellular bacteria Chlamydia trachomatis. BMC Microbiol 2008, 28 8(1): e42.
39. Pannekoek, Y., Spaargaren, J., Langerak, A., Merks, J., Morré, S.A., van der Ende, A. Interrelationship between polymorphism of incA, fusogenic properties of Chlamydia trachomatis strains. J Clin Microbiol 2005, 43(5): 2441-2443
40. Spaargaren, J., Fennema, H.S.A., Morré, S.A., de Vries, H.J.C., Coutinho, R.A. New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam. Emerg Infect Dis 2005, 11(7): 1090-1092 (Pubitemid 40880911)
41. de Vries, H.J.C., Smelov, V., Middelburg, J.G., Pleijster, J., Speksnijder, A.G.C.L., Morré, S.A. Microbial cure of lymphogranuloma venereum proctitis with doxycycline. CID 2009, 48(5): e53-6.
42. de Vries, H.J.C., van der Bij, A.K., Fennema, J.S.A. et al. Lymphogranuloma venereum proctitis in men who have sex with men is associated with anal enema use and high-risk behavior. Sex Transm Dis 2008, 35(2): 203-208
43. van Bergen, J., Götz, H.M., Richardus, J.H., Hoebe, C.J., Broer, J., Coenen, A.J.; PILOT CT study group. Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeted screening approaches: Results from the first national population based study in the Netherlands. Sex Transm Infect 2005, 81(1): 17-23.
44. van Bergen, J.E., Postma, M.J., Peerbooms, P.G., Spangenberg, A.C., Tjen-A-Tak, J., Bindels, P.J. Effectiveness and cost-effectiveness of a pharmacy-based screening programme for Chlamydia trachomatis in a high-risk health centre population in Amsterdam using mailed home-collected urine samples. Int J STD AIDS 2004, 15(12): 797-802.
45. Götz, H.M., van Bergen, J.E., Veldhuijzen, I.K. et al. Lessons learned from a population-based chlamydia screening pilot. Int J STD AIDS 2006, 17(12): 826-830 (Pubitemid 46057741)
46. Fiddelers, A.A., Land, J.A., Voss, G., Kessels, A.G., Severens, J.L. Cost-effectiveness of Chlamydia antibody tests in subfertile women. Hum Reprod 2005, 20(2): 425-432 (Pubitemid 40277611)
47. Land, J.A., van Bergen, J.E.A.M., Morré, S.A., Postma, M.J. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum Reprod Update 2009 (in press).
48. Fiddelers, A.A., Dirksen, C.D., Dumoulin, J.C. et al. Cost-effectiveness of seven IVF strategies: Results of a Markov decision-analytic model. Hum Reprod 2009, 24(7): 1648-1655
49. Vincelette, J., Schirm, J., Bogard, M. et al. Multicenter evaluation of the fully automated COBAS AMPLICOR PCR test for detection of Chlamydia trachomatis in urogenital specimens. J Clin Microbiol 1999, 37(1): 74-80. (Pubitemid 29004183)
50. Morré, S.A., Catsburg, A., de Boer, M. et al. Monitoring the potential introduction of the Swedish Chlamydia trachomatis variant (swCT) in the Netherlands. Euro Surveill 2007, 12(10): E9-10.
51. Verkooyen, R.P., Noordhoek, G.T., Klapper, P.E. et al. Reliability of nucleic acid amplification methods for detection of Chlamydia trachomatis in urine: Results of the first international collaborative quality control study among 96 laboratories. J Clin Microbiol 2003, 41(7): 3013-3016
52. van der Helm, J.J., Hoebe, C.J., van Rooijen, M.S., Brouwers, E.E., Fennema, H.S., Thiesbrummel, H.F., Dukers-Muijrers, N.H. High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women. Sex Transm Dis 2009, 36(8): 493-497
53. Götz, H.M., van Bergen, J.E., Veldhuijzen, I.K. et al. Lessons learned from a population-based chlamydia screening pilot. Int J STD AIDS 2006, 17(12): 826-830 (Pubitemid 46057741)
54. van Bergen, J., Götz, H., Richardus, J.H., Hoebe, C., Broer, J., Coenen T, PILOT CT Study Group. Prevalence of urogenital Chlamydia trachomatis infections in the Netherlands suggests selective screening approaches. Results from the PILOT CT Population Study. Drugs Today (Barc) 2006, 42(Suppl. A): 25-33.
55. Richardus, J.H., Götz, H.M. Risk selection and targeted interventions in community-based control of chlamydia. Curr Opin Infect Dis 2007, 20(1): 60-65
56. Götz, H.M., Veldhuijzen, I.K., Ossewaarde, J.M., de Zwart, O., Richardus, J.H. Chlamydia trachomatis infections in multi-ethnic urban youth: A pilot combining STI health education and outreach testing in Rotterdam, Netherlands. Sex Transm Infect 2006, 82(2): 148-152